AlloSource: Research shows ProChondrix maintains high cell viability
CENTENNIAL -- AlloSource announced research results showing ProChondrix CR maintains consistent, high cell viability for two years when stored at -80̊ C. Allosource said the research found... Read More
Tuesday October 8, 2019
AlloSource announces first patient enrolled in cartilage defect study
CENTENNIAL -- AlloSource, an organization dedicated to advancing the science and use of transplantable allogeneic cells and tissue, announced it enrolled the first patient in a study titled A... Read More
Thursday March 21, 2019
AlloSource granted patent for proprietary tissue laser cutting enclosure
CENTENNIAL -- AlloSource announced it received U.S. patent 10,105,793, titled Enclosure for laser cutting of human tissue . This patent encompasses AlloSource's method of producing a closed... Read More
Monday November 19, 2018
AlloSource, Stryker announce launch of ProChondrix CR allograft for cartilage repair
CENTENNIAL -- AlloSource and Stryker jointly announced the launch of ProChondrix CR, a single-stage, natural solution for patients in need of articular cartilage repair. AlloSource said... Read More
Monday April 9, 2018
IN Sponsors
Browse
Entrepreneurial by Nature
